FLT1 Antikörper (AA 1-328)
Kurzübersicht für FLT1 Antikörper (AA 1-328) (ABIN7567674)
Target
Alle FLT1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 1-328
-
Verwendungszweck
- Anti-Human FLT1 Monoclonal Antibody (1A112)
-
Aufreinigung
- Protein G purified from mice ascites.
-
Reinheit
- >95 %
-
Immunogen
- Mammalian cells - derived recombinant Human FLT1 (Met1-Ile328).
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
-
- FLT1 (Fms-Related tyrosine Kinase 1 (VEGFR1) (FLT1))
-
Andere Bezeichnung
- FLT1
-
Hintergrund
- FLT1,Vascular endothelial growth factor receptor 1,VEGFR1,Vascular permeability factor receptor,FRT,Tyrosine-protein kinase receptor FLT,VEGFR-1,FLT,FLT-1,Tyrosine-protein kinase FRT,Fms-like tyrosine kinase 1,Drug Target
-
Pathways
- RTK Signalweg, Signaling Events mediated by VEGFR1 and VEGFR2, VEGFR1 Specific Signals
Target
-